TenofovirVirological breakthrough following drug resistance in chronic hepatitis B: case report

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2015年 / 1559卷 / 1期

关键词：

D O I：

10.1007/s40278-015-3354-z

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：165 / 165

相关论文

共 50 条

[1] EntecavirDevelopment of virological breakthrough and drug-resistant mutants in chronic hepatitis B: case report
Reactions Weekly, 2018, 1697 (1) : 159 - 159
[2] LamivudineAcquired drug resistance in chronic hepatitis-B infection: case report
Reactions Weekly, 2019, 1776 (1) : 258 - 258
[3] EntecavirEmergence of resistance in chronic hepatitis B: case report
Reactions Weekly, 2015, 1581 (1) : 139 - 139
[4] TelbivudineDevelopment of drug resistance during treatment of chronic hepatitis B virus infection: case report
Reactions Weekly, 2021, 1857 (1) : 318 - 318
[5] LamivudineLamivudine Resistance in chronic active hepatitis B: case report
Reactions Weekly, 2015, 1545 (1) : 147 - 147
[6] EntecavirVirological breakthrough due to emergence of entecavir resistance in hepatitis B infection: case report
Reactions Weekly, 2015, 1578 (1) : 133 - 133
[7] EntecavirDevelopment of entecavir resistance in the treatment of chronic hepatitis B: case report
Reactions Weekly, 2018, 1710 (1) : 132 - 132
[8] EntecavirDevelopment of genotypic resistance in chronic hepatitis B infection: case report
Reactions Weekly, 2014, 1507 (1) : 16 - 16
[9] Treatment of chronic hepatitis B and drug resistance
Nazzal, Khalil
PRZEGLAD GASTROENTEROLOGICZNY, 2009, 4 (01): : 7 - 11
[10] Immunosuppressants/entecavirHepatitis B reactivation and acquired drug resistance: case report
Reactions Weekly, 2022, 1902 (1) : 244 - 244

← 1 2 3 4 5 →